We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
OTHER THERAPEUTIC AREAS. Film coated tablets for oral uses


Lesvi also offers a portfolio for a range of other therapeutic areas such as antiemetic, anti-infective, cardiovascular, pain and respiratory diseases.
Product Indication Dosage form Strength
Ondansetron Nausea & vomiting Orodispersable tablets 4 and 8 mg
Otilonium bromide Irritable bowel syndrome Film-coated tablets 40 mg
Paracetamol / Tramadol Analgesic Effervescent tablets 325/37.5 mg
Prasugrel Base Prophylaxis and therapy of thrombosis Film-coated tablets 5 and 10 mg
Rivaroxaban Thrombosis, stroke Film-coated tablets 10, 15 and 20 mg
Rizatriptan Migraine Orodispersable tablets 5 and 10 mg
Solifenacin Overactive bladder, urinary incontinence Film-coated tablets 5 and 10 mg
Telmisartan Hypertension Tablets 20, 40 and 80 mg
Valsartan Hypertension Film-coated tablets 40, 80, 160 and 320 mg
Zolmitriptan Migraine Orodispersable tablets 2.5 and 5 mg

[*] Differentiated product
[**] Opioid

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.

© Neuraxpharm / LESVI. All rights reserved.